We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Celanese (CE) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates
Read MoreHide Full Article
Wall Street analysts forecast that Celanese (CE - Free Report) will report quarterly earnings of $2.84 per share in its upcoming release, pointing to a year-over-year increase of 13.6%. It is anticipated that revenues will amount to $2.68 billion, exhibiting a decline of 1.4% compared to the year-ago quarter.
The current level reflects a downward revision of 3.9% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
In light of this perspective, let's dive into the average estimates of certain Celanese metrics that are commonly tracked and forecasted by Wall Street analysts.
Analysts predict that the 'Net Sales- Acetyl Chain' will reach $1.23 billion. The estimate indicates a change of +1% from the prior-year quarter.
The consensus among analysts is that 'Net Sales- Engineered Materials' will reach $1.49 billion. The estimate suggests a change of -2.8% year over year.
The collective assessment of analysts points to an estimated 'Operating EBITDA- Acetyl Chain' of $369.92 million. The estimate is in contrast to the year-ago figure of $365 million.
The consensus estimate for 'Operating EBITDA- Engineered Materials' stands at $381.28 million. The estimate is in contrast to the year-ago figure of $340 million.
Shares of Celanese have demonstrated returns of -6% over the past month compared to the Zacks S&P 500 composite's +1.8% change. With a Zacks Rank #5 (Strong Sell), CE is expected to lag the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Celanese (CE) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates
Wall Street analysts forecast that Celanese (CE - Free Report) will report quarterly earnings of $2.84 per share in its upcoming release, pointing to a year-over-year increase of 13.6%. It is anticipated that revenues will amount to $2.68 billion, exhibiting a decline of 1.4% compared to the year-ago quarter.
The current level reflects a downward revision of 3.9% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
In light of this perspective, let's dive into the average estimates of certain Celanese metrics that are commonly tracked and forecasted by Wall Street analysts.
Analysts predict that the 'Net Sales- Acetyl Chain' will reach $1.23 billion. The estimate indicates a change of +1% from the prior-year quarter.
The consensus among analysts is that 'Net Sales- Engineered Materials' will reach $1.49 billion. The estimate suggests a change of -2.8% year over year.
The collective assessment of analysts points to an estimated 'Operating EBITDA- Acetyl Chain' of $369.92 million. The estimate is in contrast to the year-ago figure of $365 million.
The consensus estimate for 'Operating EBITDA- Engineered Materials' stands at $381.28 million. The estimate is in contrast to the year-ago figure of $340 million.
View all Key Company Metrics for Celanese here>>>
Shares of Celanese have demonstrated returns of -6% over the past month compared to the Zacks S&P 500 composite's +1.8% change. With a Zacks Rank #5 (Strong Sell), CE is expected to lag the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>